Dakota Wealth Management Dexcom Inc Transaction History

Dakota Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$86.06 - $137.93 $103,788 - $166,343	-1,206 Reduced 24.15%	3,788 $353,000
Q2 2023 Jul 31, 2023	BUY	$112.47 - $130.98 $210,206 - $244,801	1,869 Added 59.81%	4,994 $641,000
Q1 2023 Apr 14, 2023	SELL	$104.0 - $122.92 $261,456 - $309,020	-2,514 Reduced 44.58%	3,125 $363,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $162,056 - $233,931	1,907 Added 51.1%	5,639 $638,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $284,938 - $351,479	3,732 New	3,732 $301,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $191,640 - $265,217	-2,037 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $264,545 - $331,664	2,037 New	2,037 $1.09 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Dakota Wealth Management with notifications on news.